Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762703
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762703Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metasta...BreakBio Corp
NCT07762196
Measuring the Effects of Music-Listening On Distress After Intensive CareNHS FifeNot Yet RecruitingNot Applicable
NCT07762196Not Yet Recruiting
Not Applicable
Measuring the Effects of Music-Listening On Distress After Intensive CareNHS Fife
NCT07763795
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and QOL in Individuals With Type 2 DiabetesSuperior UniversityActive Not RecruitingNot Applicable
NCT07763795Active Not Recruiting
Not Applicable
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and Q...Superior University
NCT07762443
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia AreataJiangsu vcare pharmaceutical technology co., LTDNot Yet RecruitingPhase 1
NCT07762443Not Yet Recruiting
Phase 1
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Are...Jiangsu vcare pharmaceuti...
NCT07762001
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MDActive Not RecruitingPhase 1
NCT07762001Active Not Recruiting
Phase 1
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MD
NCT07762638
Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated in Study ID-069A302Idorsia Pharmaceuticals Ltd.Unknown
NCT07762638Unknown
—
Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated...Idorsia Pharmaceuticals L...
NCT07764029
Efficacy of PRF and Xenograft in Treating Mandibular Molar Furcation InvolvementsUniversity of Medicine and Pharmacy at Ho Chi Minh CityRecruitingNot Applicable
NCT07764029Recruiting
Not Applicable
Efficacy of PRF and Xenograft in Treating Mandibular Molar Furcation Involvement...University of Medicine an...
NCT07763184
mNGS for IFD in Patients With Hematological MalignanciesNanfang Hospital, Southern Medical UniversityNot Yet Recruiting
NCT07763184Not Yet Recruiting
—
mNGS for IFD in Patients With Hematological MalignanciesNanfang Hospital, Souther...
NCT07762326
Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple SclerosisCairo UniversityNot Yet RecruitingNot Applicable
NCT07762326Not Yet Recruiting
Not Applicable
Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders an...Cairo University
NCT07763977
The Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on Inhibitory Control in Obsessive-Compulsive DisorderGuangdong Provincial People's HospitalEnrolling By InvitationNot Applicable
NCT07763977Enrolling By Invitation
Not Applicable
The Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on In...Guangdong Provincial Peop...
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07763028
Intrathecal Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells for Children With Cerebral PalsyGadjah Mada UniversityActive Not RecruitingPhase 1
NCT07763028Active Not Recruiting
Phase 1
Intrathecal Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells for Children...Gadjah Mada University
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07762339
Comparison of Erector Spinae Plane Block and Caudal Block for Postoperative Analgesia in Pediatric Patients Undergoing Orchiopexy: A Prospective Observational StudyProf. Dr. Cemil Tascıoglu Education and Research Hospital OrganizationRecruiting
NCT07762339Recruiting
—
Comparison of Erector Spinae Plane Block and Caudal Block for Postoperative Anal...Prof. Dr. Cemil Tascıoglu...
NCT07761988
The FamilyStrong Pilot Randomized TrialAmerican Cancer Society, Inc.Not Yet RecruitingNot Applicable
NCT07761988Not Yet Recruiting
Not Applicable
The FamilyStrong Pilot Randomized TrialAmerican Cancer Society,...
NCT07763041
Effect of QR Code-Supported Infant Care Education on Maternal Self-Confidence, Maternal Attachment, and Infant Health in the NICUAnkara Medipol UniversityCompletedNot Applicable
NCT07763041Completed
Not Applicable
Effect of QR Code-Supported Infant Care Education on Maternal Self-Confidence, M...Ankara Medipol University
NCT07762131
AI-Based Precision Transfusion Prediction Model in Critically Ill PatientsSecond Affiliated Hospital, Zhejiang University, School of MedicineNot Yet Recruiting
NCT07762131Not Yet Recruiting
—
AI-Based Precision Transfusion Prediction Model in Critically Ill PatientsSecond Affiliated Hospita...
NCT07762014
rBCG-N-RSV Vaccine in Adults Aged 60 Years and OlderBiothervax SpANot Yet RecruitingPhase 2
NCT07762014Not Yet Recruiting
Phase 2
rBCG-N-RSV Vaccine in Adults Aged 60 Years and OlderBiothervax SpA
Result Breakdown
Not yet recruiting10 (50%)
Active, not recruiting3 (15%)
Recruiting3 (15%)
Completed2 (10%)
Unknown1 (5%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 14 (20%)
Phase 22 (10%)
Phase 41 (5%)